Neoadjuvant chemotherapy in the treatment of rectal cancer without mesorectal fascia involvement but with negative prognostic factors
This article discusses the possibility of neoadjuvant chemotherapy without radiotherapy in patients suffering from rectal cancer without mesorectal fascia involvement but with negative prognostic factors. It analyzes possible risks and benefits of such an approach and provides the data of clinical t...
Main Authors: | S. O. Kochkina, S. S. Gordeev, Z. Z. Mamedli |
---|---|
Format: | Article |
Language: | Russian |
Published: |
“ABV-press” Publishing house”, LLC
2020-08-01
|
Series: | Тазовая хирургия и онкология |
Subjects: | |
Online Access: | https://ok.abvpress.ru/jour/article/view/474 |
Similar Items
-
Neoadjuvant chemotherapy in the combination treatment for locally advanced rectal cancer: currently available options
by: D. V. Kuzmichev, et al.
Published: (2018-11-01) -
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Huaqin Lin, et al.
Published: (2021-05-01) -
Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy
by: Daigo Kobayashi, et al.
Published: (2018-09-01) -
Total neoadjuvant therapy in locally advanced rectal cancer: Role of systemic chemotherapy
by: Ri Na Yoo, et al.
Published: (2019-07-01) -
Effect of neoadjuvant chemotherapy on immune function, vascular endothelial function and LEP in patients with rectal cancer
by: Jun Tang, et al.
Published: (2019-01-01)